Status:
TERMINATED
Project Movement/Daily Move Feasibility
Lead Sponsor:
Calm.com, Inc.
Conditions:
Stress
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test the feasibility (acceptability and demand) of the Daily Move in a diverse sample of US adults. Acceptability benchmarks: 214 participants recruited within three mo...
Detailed Description
Generalized stress among adults is an increasingly problematic concern, particularly in recent years due to the COVID-19 pandemic. According to the Stress in America 2020 data, Americans are still str...
Eligibility Criteria
Inclusion
- Aged 18 years or older
- Score of 6 or greater on the Perceived Stress Scale-4
Exclusion
- Subscribe to Calm or use Calm
- Live outside of the United States of America
- Unable to read or understand English
Key Trial Info
Start Date :
January 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT05248711
Start Date
January 6 2022
End Date
August 1 2022
Last Update
August 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Calm, Inc.
San Francisco, California, United States, 94105